Patents by Inventor Carl Kozlosky

Carl Kozlosky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-mesothelin binding proteins
    Patent number: 11866508
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: January 9, 2024
    Assignee: AMGEN INC.
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Gudas
  • ANTI-MESOTHELIN BINDING PROTEINS
    Publication number: 20210380714
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Application
    Filed: January 6, 2021
    Publication date: December 9, 2021
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Gudas
  • Anti-mesothelin binding proteins
    Patent number: 10919975
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: February 16, 2021
    Assignee: AMGEN INC.
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Marie Gudas
  • ANTI-MESOTHELIN BINDING PROTEINS
    Publication number: 20190055316
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Application
    Filed: September 6, 2018
    Publication date: February 21, 2019
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Marie Gudas
  • Anti-mesothelin binding proteins
    Patent number: 10100121
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: October 16, 2018
    Assignee: AMGEN INC.
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Marie Gudas
  • ANTI-MESOTHELIN BINDING PROTEINS
    Publication number: 20160340440
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Application
    Filed: April 28, 2016
    Publication date: November 24, 2016
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Marie Gudas
  • ANTI-MESOTHELIN BINDING PROTEINS
    Publication number: 20140004121
    Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which specifically bind to mesothelin. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies, including methods of treating and preventing cancer or other hypoproliferative disorders and related disorders by administering such antigen binding proteins and antibodies to a subject in need of such treatment.
    Type: Application
    Filed: June 25, 2013
    Publication date: January 2, 2014
    Inventors: William Christian Fanslow, III, Carl Kozlosky, Jean Marie Gudas